New combo therapy shows promise for Hard-to-Treat colorectal cancer
Disease control
Completed
This study tested whether adding an immunotherapy drug (nivolumab) to standard chemotherapy could help control metastatic colorectal cancer that is not sensitive to immunotherapy alone. The trial involved 80 adults with advanced disease who had not received prior treatment. The m…
Phase: PHASE2 • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated May 01, 2026 16:01 UTC